Aditxt, Inc. Proceeds from (Payments for) Other Financing Activities
Aditxt, Inc. (ADTX) reported Proceeds from (Payments for) Other Financing Activities of -$262.16 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2023-11-14
- 2023-09-30: Proceeds from (Payments for) Other Financing Activities 9 month -$262.16K.
- 2022-09-30: Proceeds from (Payments for) Other Financing Activities 9 month -$563.75K.
| Period end | Proceeds from (Payments for) Other Financing Activities 9 month |
|---|---|
| 2023-09-30 | -$262.16K 10-Q · filed 2023-11-14 |
| 2022-09-30 | -$563.75K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |